Home > > > > Report Detail

Global Biotherapeutics Cell Line Development Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Publisher Name :
Date: 14-Sep-2022
No. of pages: 107
Inquire Before Buying

Report Scope

This latest report researches the industry structure, revenue and gross margin. Major players' headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biotherapeutics Cell Line Development companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Biotherapeutics Cell Line Development market. Further, it explains the major drivers and regional dynamics of the global Biotherapeutics Cell Line Development market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

- Becton Dickinson & Company

- Beckman Coulter

- Boehringer Ingelheim Group

- Catalent Inc.

- CMC Biologics A/S

- Lonza Group Ltd.

- EMD Millipore

- Partec (Sysmex Corporation)

- ProBioGen AG

- Selexis SA

- Sigma-Aldrich Co. LLC.

- Sony Biotechnology Inc.

- Thermo Fisher Scientific Inc.

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028.

Biotherapeutics Cell Line Development Segment by Type

- Transfection & Selection

- Single Cell Cloning

Biotherapeutics Cell Line Development Segment by Application

- In-house

- Outsource

- Hybrid

- Do-It-Yourself (DIY)

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Biotherapeutics Cell Line Development market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Biotherapeutics Cell Line Development market size. Analyses of the global market trends, with historic market revenue data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Biotherapeutics Cell Line Development, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Biotherapeutics Cell Line Development, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biotherapeutics Cell Line Development revenue, market share and industry ranking of main companies, data from 2017 to 2022. Identification of the major stakeholders in the global Biotherapeutics Cell Line Development market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2017 to 2028. Evaluation and forecast the market size for Biotherapeutics Cell Line Development revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent Inc., CMC Biologics A/S, Lonza Group Ltd., EMD Millipore, Partec (Sysmex Corporation) and ProBioGen AG, etc.

Global Biotherapeutics Cell Line Development Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Transfection & Selection
1.2.3 Single Cell Cloning
1.3 Market by Application
1.3.1 Global Biotherapeutics Cell Line Development Market Growth Rate by Application: 2017 VS 2021 VS 2028
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Study Objectives
1.5 Years Considered
2 Market Perspective
2.1 Global Biotherapeutics Cell Line Development Market Size (2017-2028)
2.2 Biotherapeutics Cell Line Development Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028
2.3 Global Biotherapeutics Cell Line Development Market Size by Region (2017-2022)
2.4 Global Biotherapeutics Cell Line Development Market Size Forecast by Region (2023-2028)
2.5 Global Top Biotherapeutics Cell Line Development Countries Ranking by Market Size
3 Biotherapeutics Cell Line Development Competitive by Company
3.1 Global Biotherapeutics Cell Line Development Revenue by Players
3.1.1 Global Biotherapeutics Cell Line Development Revenue by Players (2017-2022)
3.1.2 Global Biotherapeutics Cell Line Development Market Share by Players (2017-2022)
3.2 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Company Covered: Ranking by Biotherapeutics Cell Line Development Revenue
3.4 Global Biotherapeutics Cell Line Development Market Concentration Ratio
3.4.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2021
3.5 Global Biotherapeutics Cell Line Development Key Players Head office and Area Served
3.6 Key Players Biotherapeutics Cell Line Development Product Solution and Service
3.7 Date of Enter into Biotherapeutics Cell Line Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Global Biotherapeutics Cell Line Development Breakdown Data by Type
4.1 Global Biotherapeutics Cell Line Development Historic Revenue by Type (2017-2022)
4.2 Global Biotherapeutics Cell Line Development Forecasted Revenue by Type (2023-2028)
5 Global Biotherapeutics Cell Line Development Breakdown Data by Application
5.1 Global Biotherapeutics Cell Line Development Historic Market Size by Application (2017-2022)
5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Biotherapeutics Cell Line Development Revenue by Company (2020-2022)
6.2 North America Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
6.3 North America Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
6.4 North America Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
6.4.1 U.S.
6.4.2 Canada
7 Europe
7.1 Europe Biotherapeutics Cell Line Development Revenue by Company (2020-2022)
7.2 Europe Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
7.3 Europe Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
7.4 Europe Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
8 Asia Pacific
8.1 Asia Pacific Biotherapeutics Cell Line Development Revenue by Company (2020-2022)
8.2 Asia Pacific Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
8.3 Asia Pacific Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
8.4 Asia Pacific Biotherapeutics Cell Line Development Revenue by Region (2017-2028)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 India
8.4.5 Australia
8.4.6 Taiwan
8.4.7 Indonesia
8.4.8 Thailand
8.4.9 Malaysia
8.4.10 Philippines
8.4.11 Vietnam
9 Latin America
9.1 Latin America Biotherapeutics Cell Line Development Revenue by Company (2020-2022)
9.2 Latin America Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
9.3 Latin America Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
9.4 Latin America Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
9.4.1 Mexico
9.4.2 Brazil
9.4.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Biotherapeutics Cell Line Development Revenue by Company (2020-2022)
10.2 Middle East and Africa Biotherapeutics Cell Line Development Revenue by Type (2017-2028)
10.3 Middle East and Africa Biotherapeutics Cell Line Development Revenue by Application (2017-2028)
10.4 Middle East and Africa Biotherapeutics Cell Line Development Revenue by Country (2017-2028)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 U.A.E
11 Company Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Details
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Products and Services
11.1.4 Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.1.5 Becton Dickinson & Company Biotherapeutics Cell Line Development SWOT Analysis
11.1.6 Becton Dickinson & Company Recent Developments
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biotherapeutics Cell Line Development Products and Services
11.2.4 Beckman Coulter Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.2.5 Beckman Coulter Biotherapeutics Cell Line Development SWOT Analysis
11.2.6 Beckman Coulter Recent Developments
11.3 Boehringer Ingelheim Group
11.3.1 Boehringer Ingelheim Group Company Details
11.3.2 Boehringer Ingelheim Group Business Overview
11.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Products and Services
11.3.4 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.3.5 Boehringer Ingelheim Group Biotherapeutics Cell Line Development SWOT Analysis
11.3.6 Boehringer Ingelheim Group Recent Developments
11.4 Catalent Inc.
11.4.1 Catalent Inc. Company Details
11.4.2 Catalent Inc. Business Overview
11.4.3 Catalent Inc. Biotherapeutics Cell Line Development Products and Services
11.4.4 Catalent Inc. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.4.5 Catalent Inc. Biotherapeutics Cell Line Development SWOT Analysis
11.4.6 Catalent Inc. Recent Developments
11.5 CMC Biologics A/S
11.5.1 CMC Biologics A/S Company Details
11.5.2 CMC Biologics A/S Business Overview
11.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Products and Services
11.5.4 CMC Biologics A/S Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.5.5 CMC Biologics A/S Biotherapeutics Cell Line Development SWOT Analysis
11.5.6 CMC Biologics A/S Recent Developments
11.6 Lonza Group Ltd.
11.6.1 Lonza Group Ltd. Company Details
11.6.2 Lonza Group Ltd. Business Overview
11.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Products and Services
11.6.4 Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.6.5 Lonza Group Ltd. Biotherapeutics Cell Line Development SWOT Analysis
11.6.6 Lonza Group Ltd. Recent Developments
11.7 EMD Millipore
11.7.1 EMD Millipore Company Details
11.7.2 EMD Millipore Business Overview
11.7.3 EMD Millipore Biotherapeutics Cell Line Development Products and Services
11.7.4 EMD Millipore Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.7.5 EMD Millipore Biotherapeutics Cell Line Development SWOT Analysis
11.7.6 EMD Millipore Recent Developments
11.8 Partec (Sysmex Corporation)
11.8.1 Partec (Sysmex Corporation) Company Details
11.8.2 Partec (Sysmex Corporation) Business Overview
11.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Products and Services
11.8.4 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.8.5 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development SWOT Analysis
11.8.6 Partec (Sysmex Corporation) Recent Developments
11.9 ProBioGen AG
11.9.1 ProBioGen AG Company Details
11.9.2 ProBioGen AG Business Overview
11.9.3 ProBioGen AG Biotherapeutics Cell Line Development Products and Services
11.9.4 ProBioGen AG Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.9.5 ProBioGen AG Biotherapeutics Cell Line Development SWOT Analysis
11.9.6 ProBioGen AG Recent Developments
11.10 Selexis SA
11.10.1 Selexis SA Company Details
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Biotherapeutics Cell Line Development Products and Services
11.10.4 Selexis SA Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.10.5 Selexis SA Biotherapeutics Cell Line Development SWOT Analysis
11.10.6 Selexis SA Recent Developments
11.11 Sigma-Aldrich Co. LLC.
11.11.1 Sigma-Aldrich Co. LLC. Company Details
11.11.2 Sigma-Aldrich Co. LLC. Business Overview
11.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Products and Services
11.11.4 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.11.5 Sigma-Aldrich Co. LLC. Recent Developments
11.12 Sony Biotechnology Inc.
11.12.1 Sony Biotechnology Inc. Company Details
11.12.2 Sony Biotechnology Inc. Business Overview
11.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Products and Services
11.12.4 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.12.5 Sony Biotechnology Inc. Recent Developments
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Details
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Products and Services
11.13.4 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022)
11.13.5 Thermo Fisher Scientific Inc. Recent Developments
12 Biotherapeutics Cell Line Development Market Dynamics
12.1 Biotherapeutics Cell Line Development Market Trends
12.2 Biotherapeutics Cell Line Development Market Drivers
12.3 Biotherapeutics Cell Line Development Market Challenges
12.4 Biotherapeutics Cell Line Development Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
List of Tables
Table 1. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Transfection & Selection
Table 3. Key Players of Single Cell Cloning
Table 4. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Biotherapeutics Cell Line Development Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 6. Global Biotherapeutics Cell Line Development Revenue by Region (2017-2022) & (US$ Million)
Table 7. Global Biotherapeutics Cell Line Development Revenue Market Share by Region (2017-2022)
Table 8. Global Biotherapeutics Cell Line Development Revenue by Players (2017-2022) & (US$ Million)
Table 9. Global Biotherapeutics Cell Line Development Market Share by Players (2017-2022)
Table 10. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2021)
Table 11. Ranking of Global Top Biotherapeutics Cell Line Development Companies by Revenue (US$ Million) in 2021
Table 12. Global 5 Largest Players Market Share by Biotherapeutics Cell Line Development Revenue (CR5 and HHI) & (2017-2022)
Table 13. Key Players Headquarters and Area Served
Table 14. Key Players Biotherapeutics Cell Line Development Product Solution and Service
Table 15. Date of Key Manufacturers Enter into Biotherapeutics Cell Line Development Market
Table 16. Mergers & Acquisitions, Expansion Plans
Table 17. Global Biotherapeutics Cell Line Development Market Size by Type (2017-2022) & (US$ Million)
Table 18. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2022)
Table 19. Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 20. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2023-2028)
Table 21. Global Biotherapeutics Cell Line Development Market Size by Application (2017-2022) & (US$ Million)
Table 22. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2022)
Table 23. Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2023-2028)
Table 25. North America Biotherapeutics Cell Line Development Revenue by Company (2020-2022) & (US$ Million)
Table 26. North America Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (US$ Million)
Table 27. North America Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (US$ Million)
Table 28. North America Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (US$ Million)
Table 29. North America Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (US$ Million)
Table 30. North America Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (US$ Million)
Table 31. North America Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (US$ Million)
Table 32. Europe Biotherapeutics Cell Line Development Revenue by Company (2020-2022) & (US$ Million)
Table 33. Europe Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (US$ Million)
Table 34. Europe Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (US$ Million)
Table 35. Europe Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (US$ Million)
Table 36. Europe Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (US$ Million)
Table 37. Europe Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (US$ Million)
Table 38. Europe Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (US$ Million)
Table 39. Asia Pacific Biotherapeutics Cell Line Development Revenue by Company (2020-2022) & (US$ Million)
Table 40. Asia Pacific Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (US$ Million)
Table 41. Asia Pacific Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (US$ Million)
Table 42. Asia Pacific Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (US$ Million)
Table 43. Asia Pacific Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (US$ Million)
Table 44. Asia Pacific Biotherapeutics Cell Line Development Revenue by Region (2017-2022) & (US$ Million)
Table 45. Asia Pacific Biotherapeutics Cell Line Development Revenue by Region (2023-2028) & (US$ Million)
Table 46. Latin America Biotherapeutics Cell Line Development Revenue by Company (2020-2022) & (US$ Million)
Table 47. Latin America Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (US$ Million)
Table 48. Latin America Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (US$ Million)
Table 49. Latin America Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (US$ Million)
Table 50. Latin America Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (US$ Million)
Table 51. Latin America Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (US$ Million)
Table 52. Latin America Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (US$ Million)
Table 53. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Company (2020-2022) & (US$ Million)
Table 54. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Type (2017-2022) & (US$ Million)
Table 55. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Type (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Application (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Application (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Country (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Biotherapeutics Cell Line Development Revenue by Country (2023-2028) & (US$ Million)
Table 60. Becton Dickinson & Company Company Details
Table 61. Becton Dickinson & Company Business Overview
Table 62. Becton Dickinson & Company Biotherapeutics Cell Line Development Product and Services
Table 63. Becton Dickinson & Company Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 64. Becton Dickinson & Company Biotherapeutics Cell Line Development SWOT Analysis
Table 65. Becton Dickinson & Company Recent Developments
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Biotherapeutics Cell Line Development Product and Services
Table 69. Beckman Coulter Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 70. Beckman Coulter Biotherapeutics Cell Line Development SWOT Analysis
Table 71. Beckman Coulter Recent Developments
Table 72. Boehringer Ingelheim Group Company Details
Table 73. Boehringer Ingelheim Group Business Overview
Table 74. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product and Services
Table 75. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 76. Boehringer Ingelheim Group Biotherapeutics Cell Line Development SWOT Analysis
Table 77. Boehringer Ingelheim Group Recent Developments
Table 78. Catalent Inc. Company Details
Table 79. Catalent Inc. Business Overview
Table 80. Catalent Inc. Biotherapeutics Cell Line Development Product and Services
Table 81. Catalent Inc. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 82. Catalent Inc. Biotherapeutics Cell Line Development SWOT Analysis
Table 83. Catalent Inc. Recent Developments
Table 84. CMC Biologics A/S Company Details
Table 85. CMC Biologics A/S Business Overview
Table 86. CMC Biologics A/S Biotherapeutics Cell Line Development Product and Services
Table 87. CMC Biologics A/S Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 88. CMC Biologics A/S Biotherapeutics Cell Line Development SWOT Analysis
Table 89. CMC Biologics A/S Recent Developments
Table 90. Lonza Group Ltd. Company Details
Table 91. Lonza Group Ltd. Business Overview
Table 92. Lonza Group Ltd. Biotherapeutics Cell Line Development Product and Services
Table 93. Lonza Group Ltd. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 94. Lonza Group Ltd. Biotherapeutics Cell Line Development SWOT Analysis
Table 95. Lonza Group Ltd. Recent Developments
Table 96. EMD Millipore Company Details
Table 97. EMD Millipore Business Overview
Table 98. EMD Millipore Biotherapeutics Cell Line Development Product and Services
Table 99. EMD Millipore Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 100. EMD Millipore Biotherapeutics Cell Line Development SWOT Analysis
Table 101. EMD Millipore Recent Developments
Table 102. Partec (Sysmex Corporation) Company Details
Table 103. Partec (Sysmex Corporation) Business Overview
Table 104. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product and Services
Table 105. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 106. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development SWOT Analysis
Table 107. Partec (Sysmex Corporation) Recent Developments
Table 108. ProBioGen AG Company Details
Table 109. ProBioGen AG Business Overview
Table 110. ProBioGen AG Biotherapeutics Cell Line Development Product and Services
Table 111. ProBioGen AG Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 112. ProBioGen AG Biotherapeutics Cell Line Development SWOT Analysis
Table 113. ProBioGen AG Recent Developments
Table 114. Selexis SA Company Details
Table 115. Selexis SA Business Overview
Table 116. Selexis SA Biotherapeutics Cell Line Development Product and Services
Table 117. Selexis SA Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 118. Selexis SA Biotherapeutics Cell Line Development SWOT Analysis
Table 119. Selexis SA Recent Developments
Table 120. Sigma-Aldrich Co. LLC. Company Details
Table 121. Sigma-Aldrich Co. LLC. Business Overview
Table 122. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product and Services
Table 123. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 124. Sigma-Aldrich Co. LLC. Recent Developments
Table 125. Sony Biotechnology Inc. Company Details
Table 126. Sony Biotechnology Inc. Business Overview
Table 127. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product and Services
Table 128. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 129. Sony Biotechnology Inc. Recent Developments
Table 130. Thermo Fisher Scientific Inc. Company Details
Table 131. Thermo Fisher Scientific Inc. Business Overview
Table 132. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product and Services
Table 133. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Revenue in Biotherapeutics Cell Line Development Business (2017-2022) & (US$ Million)
Table 134. Thermo Fisher Scientific Inc. Recent Developments
Table 135. Biotherapeutics Cell Line Development Market Trends
Table 136. Biotherapeutics Cell Line Development Market Drivers
Table 137. Biotherapeutics Cell Line Development Market Challenges
Table 138. Biotherapeutics Cell Line Development Market Restraints
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotherapeutics Cell Line Development Sales Market Share by Type: 2021 VS 2028
Figure 2. Transfection & Selection Features
Figure 3. Single Cell Cloning Features
Figure 4. Global Biotherapeutics Cell Line Development Sales Market Share by Application: 2021 VS 2028
Figure 5. In-house Case Studies
Figure 6. Outsource Case Studies
Figure 7. Hybrid Case Studies
Figure 8. Do-It-Yourself (DIY) Case Studies
Figure 9. Biotherapeutics Cell Line Development Report Years Considered
Figure 10. Global Biotherapeutics Cell Line Development Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Biotherapeutics Cell Line Development Market Size 2017-2028 (US$ Million)
Figure 12. Global Biotherapeutics Cell Line Development Market Size Market Share by Region: 2021 VS 2028
Figure 13. Global Biotherapeutics Cell Line Development Revenue Market Share by Region in 2017 VS 2022
Figure 14. Global Top 10 Biotherapeutics Cell Line Development Countries Ranking by Market Size (US$ Million) in 2021
Figure 15. Global Biotherapeutics Cell Line Development Market Share by Players in 2021
Figure 16. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Biotherapeutics Cell Line Development Revenue in 2021
Figure 18. North America Biotherapeutics Cell Line Development Revenue Market Share by Company in 2021
Figure 19. North America Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2028)
Figure 20. North America Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2028)
Figure 21. North America Biotherapeutics Cell Line Development Revenue Share by Country (2017-2028)
Figure 22. U.S. Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 23. Canada Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 24. Europe Biotherapeutics Cell Line Development Revenue Market Share by Company in 2021
Figure 25. Europe Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2028)
Figure 26. Europe Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2028)
Figure 27. Europe Biotherapeutics Cell Line Development Revenue Share by Country (2017-2028)
Figure 28. Germany Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 29. France Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 30. U.K. Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 31. Italy Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 32. Russia Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 33. Asia Pacific Biotherapeutics Cell Line Development Revenue Market Share by Company in 2021
Figure 34. Asia Pacific Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2028)
Figure 35. Asia Pacific Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2028)
Figure 36. Asia Pacific Biotherapeutics Cell Line Development Revenue Share by Region (2017-2028)
Figure 37. China Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 38. Japan Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 39. South Korea Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 40. India Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 41. Australia Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 42. Taiwan Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 43. Indonesia Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 44. Thailand Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 45. Malaysia Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 46. Philippines Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 47. Vietnam Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 48. Latin America Biotherapeutics Cell Line Development Revenue Market Share by Company in 2021
Figure 49. Latin America Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2028)
Figure 50. Latin America Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2028)
Figure 51. Latin America Biotherapeutics Cell Line Development Revenue Share by Country (2017-2028)
Figure 52. Mexico Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 53. Brazil Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 54. Argentina Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 55. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Company in 2021
Figure 56. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Type (2017-2028)
Figure 57. Middle East and Africa Biotherapeutics Cell Line Development Revenue Market Share by Application (2017-2028)
Figure 58. Middle East and Africa Biotherapeutics Cell Line Development Revenue Share by Country (2017-2028)
Figure 59. Turkey Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 60. Saudi Arabia Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 61. U.A.E Biotherapeutics Cell Line Development Revenue (2017-2028) & (US$ Million)
Figure 62. Becton Dickinson & Company Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 63. Beckman Coulter Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 64. Boehringer Ingelheim Group Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 65. Catalent Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 66. CMC Biologics A/S Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 67. Lonza Group Ltd. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 68. EMD Millipore Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 69. Partec (Sysmex Corporation) Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 70. ProBioGen AG Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 71. Selexis SA Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2017-2022)
Figure 72. Sigma-Aldrich Co. LLC. Revenue Growth
  • Global Scaffold Free 3D Cell Culture Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Scaffold Free 3D Cell Culture market size was valued at US$ 35 million in 2023. With growing demand in downstream market, the Scaffold Free 3D Cell Culture is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 14.0% during review period. The research report highlights the growth potential of the global Scaffold Free 3D Cell Culture market. Scaffold Free 3D Cell Culture are expected to show stable growth in......
  • Global Cell Culture Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Cell Culture market size was valued at US$ 1266.6 million in 2023. With growing demand in downstream market, the Cell Culture is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Cell Culture market. Cell Culture are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Fetal Bovine Serum Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 160
    According to our LPI (LP Information) latest study, the global Fetal Bovine Serum market size was valued at US$ 947.8 million in 2023. With growing demand in downstream market, the Fetal Bovine Serum is forecast to a readjusted size of US$ 1003.6 million by 2030 with a CAGR of 0.8% during review period. The research report highlights the growth potential of the global Fetal Bovine Serum market. Fetal Bovine Serum are expected to show stable growth in the future market. However, product d......
  • Global 3D Cell Culture Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global 3D Cell Culture market size was valued at US$ 398.5 million in 2023. With growing demand in downstream market, the 3D Cell Culture is forecast to a readjusted size of US$ 924.1 million by 2030 with a CAGR of 12.8% during review period. The research report highlights the growth potential of the global 3D Cell Culture market. 3D Cell Culture are expected to show stable growth in the future market. However, product differentiati......
  • Global 3D Cell Culture Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 138
    According to our (Global Info Research) latest study, the global 3D Cell Culture market size was valued at USD 419.1 million in 2023 and is forecast to a readjusted size of USD 913.9 million by 2030 with a CAGR of 11.8% during review period. A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro ......
  • Global Fetal Bovine Serum Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 150
    According to our (Global Info Research) latest study, the global Fetal Bovine Serum market size was valued at USD 997 million in 2023 and is forecast to a readjusted size of USD 1050.9 million by 2030 with a CAGR of 0.8% during review period. Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum album......
  • Global Scaffold Free 3D Cell Culture Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Scaffold Free 3D Cell Culture market: According to our latest research, the global Scaffold Free 3D Cell Culture market looks promising in the next 5 years. As of 2022, the global Scaffold Free 3D Cell Culture market was estimated at USD 37.31 million, and it's anticipated to reach USD 94.67 million in 2028, with a CAGR of 16.79% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Global 3D Cell Culture Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 132
    Report Overview: A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 ......
  • Global Cell Line Development Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cell Line Development market: According to our latest research, the global Cell Line Development market looks promising in the next 5 years. As of 2022, the global Cell Line Development market was estimated at USD 3709.62 million, and it's anticipated to reach USD 7485.53 million in 2028, with a CAGR of 12.41% during the forecast years. Cell lines are essential for a wide range of applications including gene function studies, drug discovery assays, t......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs